Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (40)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Karande, V.
Right arrow Articles by Gleicher, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karande, V.
Right arrow Articles by Gleicher, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 7, 1744-1748, July 1999
© 1999 European Society of Human Reproduction and Embryology

A rational approach to the management of low responders in in-vitro fertilization: Opinion

Vishvanath Karande1 and Norbert Gleicher

Center for Human Reproduction – Illinois, and the Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, Illinois, USA


    Introduction
 
Low ovarian response to stimulation occurs in ~9–24% of patients (Keay et al., 1997Go) and still represents one of the most intractable problems of infertility treatment. Clinicians have historically approached low responders in two ways. A first option is to refuse patients entry into in-vitro fertilization (IVF) cycles. Such an approach is, however, obviously discriminatory and serves no practical purpose except for protecting a programme's pregnancy rate (a rather self-serving and medically inappropriate choice). This leaves, as the only ethical choice, attempts to maximize outcomes in IVF cycles for low responders by attempting to improve their historically poor pregnancy and delivery rates.

This paper will briefly review the various stimulation protocols (successful and unsuccessful) that have been attempted to improve IVF results in low responders. Included is our experience with a protocol that has met with some success. We would also like to propose a strategy where one . . . [Full Text of this Article]


    Notes
 

    References
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
J. Balasch, F. Fabregues, J. Penarrubia, F. Carmona, R. Casamitjana, M. Creus, D. Manau, G. Casals, and J. A. Vanrell
Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH
Hum. Reprod., July 1, 2006; 21(7): 1884 - 1893.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Kan, E. H. Y. Ng, W. S. B. Yeung, and P. C. Ho
Perifollicular vascularity in poor ovarian responders during IVF
Hum. Reprod., June 1, 2006; 21(6): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. A. Vanrell, and J. Balasch
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment
Hum. Reprod., April 1, 2005; 20(4): 915 - 922.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, F. Carmona, R. Casamitjana, J. A. Vanrell, and J. Balasch
Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment
Hum. Reprod., March 1, 2005; 20(3): 622 - 628.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Kailasam, S.D. Keay, P. Wilson, W.C.L. Ford, and J.M. Jenkins
Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome
Hum. Reprod., July 1, 2004; 19(7): 1544 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.D. Keay, N.H. Liversedge, V.A. Akande, R.S. Mathur, and J.M. Jenkins
Serum IGF-1 concentrations following pituitary desensitization do not predict the ovarian response to gonadotrophin stimulation prior to IVF
Hum. Reprod., September 1, 2003; 18(9): 1797 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Nikolaou, S. Lavery, C. Turner, R. Margara, and G. Trew
Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?
Hum. Reprod., April 1, 2002; 17(4): 1106 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D.M. Ranieri, P. Phophong, I. Khadum, F. Meo, C. Davis, and P. Serhal
Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF
Hum. Reprod., April 1, 2001; 16(4): 673 - 675.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. A. Garcia-Velasco, V. Isaza, A. Requena, Fco.J. Martinez-Salazar, A. Landazabal, J. Remohi, A. Pellicer, and C. Simon
High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial
Hum. Reprod., November 1, 2000; 15(11): 2292 - 2296.
[Abstract] [Full Text] [PDF]